|Articles|February 10, 2023
SCOPE 2023: Uniting Stakeholders With Patient Centricity
Author(s)Lisa Henderson
Len Rosenberg, head of clinical operations at Beat AML, comments on how his company not helps to advance the sector, but integrates new ways to conduct clinical trials.
Advertisement
In an interview at the 2023 SCOPE conference with ACT Editor-in-Chief, Lisa Henderson, Len Rosenberg, head of clinical operations at Beat AML, explains how the company's role as a neutral third party influences his ability to bring stakeholders together.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Imfinzi Plus FLOT for Early and Locally Advanced Gastric and GEJ Cancers
2
Novo Nordisk Submits Higher-Dose Wegovy Injectable for FDA Approval with Priority Voucher
3
Is Artificial Intelligence Coming for Clinical Research?
4
The CRA Role’s Co-evolution With Clinical Trial Technology
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
